Aspira Pathlab & Diagnostics Lim (BSE: 540788) is a Mumbai, Maharashtra-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹130 Cr, it ranks #3,025 by market cap among the 6,189 Indian listed companies on FinBizNet, and #10 of 18 in Medical Diagnostic Centres. At ₹126.05 (as of 26 Oct 2026), the share price is 16.0% below its 52-week high of ₹149.99 and 133.4% above its 52-week low of ₹54.00. The share price is up 94.3% over one year and up 17.1% over three months.
| Current Price | ₹126.05 |
|---|---|
| Market Cap | ₹130 Cr |
| BSE Code | 540788 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 2,521 |
| Return on Equity | 0.42% |
| Return on Assets | -0.26% |
| 52-Week Range | ₹54.00 – ₹149.99 |
| 1-Year Price Change | +94.3% |
| 3-Month Price Change | +17.1% |
| Beta (1Y) | -0.35 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.aspiradiagnostics.com |
Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was incorporated in 1973 and is based in Mumbai, India.
1. Pathology and Diagnostics-This segment operates diagnostic centers.
1. Pathology and Diagnostics-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Limited | ₹14,311 Cr | 82.8 | 19.70% | ₹231 Cr | +40.7% |
| Metropolis Healthcare Limited | ₹10,849 Cr | 56.9 | 13.37% | ₹450 Cr | +7.3% |
| Throcare Technologies Ltd | ₹7,357 Cr | 45.3 | 28.74% | ₹240 Cr | +8.9% |
| Dr. Agarwal'S Eye Hospital Ltd | ₹2,434 Cr | 34.3 | 25.22% | — | +20.0% |
| Krsnaa Diagnostics Ltd | ₹1,617 Cr | 16.1 | 10.89% | ₹236 Cr | -38.8% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,559 Cr | 48.4 | 13.84% | ₹88 Cr | -0.3% |
| Gaudium IVF and Women Health Limited | ₹670 Cr | 23.5 | 16.08% | ₹19 Cr | — |
| Chandan Healthcare Limited | ₹535 Cr | 20.3 | — | ₹81 Cr | — |
| Aspira Pathlab & Diagnostics Lim | ₹130 Cr | 2,521 | 0.42% | — | +94.3% |
Listed by market capitalisation. Ratios are shown for context only.
Aspira Pathlab & Diagnostics Lim is trading at ₹126.05, with a market capitalisation of ₹130 Cr.
Aspira Pathlab & Diagnostics Lim operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Aspira Pathlab & Diagnostics Lim has a P/E of 2,521 and a return on equity of 0.42%.
Aspira Pathlab & Diagnostics Lim is listed on the BSE under the scrip code 540788.
Aspira Pathlab & Diagnostics Lim's share price is up 94.3% over one year and up 17.1% over three months. Its 52-week range is ₹54.00 to ₹149.99.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.